MedPath

It is a study of two modes of treatment; which are called Laser Photocoagulation alone and with drug Triamcinolone, in the patients which are suffering from eye disease caused by Diabetes Mellitus.

Phase 4
Recruiting
Conditions
Health Condition 1: null- Diabetic Macular Edema in Diabetic Retinopathy
Registration Number
CTRI/2012/08/002878
Lead Sponsor
Govt medical college and Sir Takhatsinhji General Hospital Bhavnagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1)Diagnosis of diabetes mellitus ( type or type 2).

2)Age >= 18 years.

3)Able and willing to provide informed consent.

4) Definite retinal thicking due to diabetic macular edema based on clinical examination involving the centre of the macula.

5) Media clarity, papillary dilatation, and patient cooperation sufficient

For adequate fundus photographs.

6) IOP < 25 mmHg

Exclusion Criteria

1)History of chronic renal failure requiring dialysis or kidney transplant.

2)Known allergy to any corticosteroid or any component of the delivery vehicle.

3)History of systemic (e.g. oral, IV, IM, epidural, bursal) corticosteroids within 4 ) months prior to randomization or topical, rectal or inhaled corticosteroids in current use more than 2 times per week.

5)Proliferative diabetic retinopathy.

6)Aphakia.

7)Intraocular pressure >= 25 mmHg.

8)History of open angle glaucoma.

9)History of steroid-induced intraocular pressure elevation that required IOP lowering agents.

10)History of prior treatment with intravitreal corticosteroids within 6 months prior to randomization.

11)History of focal/grid macular photocoagulation within 15 weeks (3.5 months) prior to randomization.

12)History of panretinal scatter photocoagulation (PRP) within prior 4 months or anticipated within the next 6 months following randomization.

13)History of major ocular surgery ( including cataract extraction, scleral buckle, any intraocular surgery etc.) within prior 6 months or anticipated within the next 6 months following randomization.

14)History of prior herpetic ocular infection.

15)An ocular condition is present such that visual acuity would not improve from resolution of macular edema (e.g. foveal atrophy, pigmentary changes, nonretinal conditions).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath